Physician
Plecha Durant Stanko Johnson & Cohen a Professional Corporation
Plecha Durant Stanko Johnson & Cohen a Professional Corporation was paid $2.64M by Medicaid between Jan 2018 and Nov 2024, across 19 billing codes. Its largest line is J2778, Injection, ranibizumab, 0.1 mg — 36% of everything it billed.
33Billing provider infoPLECHA DURANT STANKO JOHNSON & COHEN A PROFESSIONAL CORPORATION
RENO, NV 89502
RENO, NV 89502
33aNPI1316022551assigned 10/26/2006
33bProvider typeOphthalmology Physician
28Total paid$2.64M
24GClaims29,757
24DCodes billed19
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Ophthalmology Physician providers in Nevada
Rank by total paid#3 of 69
Median peer was paid$16K
This provider vs. median165×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,140 | $244K | |
| 2019 | 5,335 | $407K | |
| 2020 | 4,257 | $321K | |
| 2021 | 4,570 | $350K | |
| 2022 | 4,255 | $380K | |
| 2023 | 5,001 | $455K | |
| 2024incomplete | 2,199 | $481K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J2778 | Injection, ranibizumab, 0.1 mg | 36% | 1,977 | 1,393 | $963K |
| J2777 | Injection, faricimab-svoa, 0.1 mg | 13% | 238 | 213 | $340K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 11% | 4,258 | 3,846 | $289K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 9.5% | 4,873 | 4,194 | $250K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 7.3% | 1,253 | 1,183 | $193K |
| 67028 | Intravitreal injection of a pharmacologic agent | 6.2% | 2,926 | 2,397 | $163K |
| 92060 | 5.9% | 2,933 | 2,686 | $155K | |
| 92134 | 3.4% | 4,433 | 3,690 | $90K | |
| 92083 | 1.9% | 1,553 | 1,397 | $50K | |
| 92015 | Determination of refractive state | 1.4% | 2,222 | 2,065 | $38K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.1% | 313 | 286 | $28K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 426 | 369 | $22K |
7 more codes
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCASSINELLI, KELLIE (ADMINISTRATOR)